Chris Floyd

Christopher is one of tranScrip’s experts in Translational Medicine, Clinical Pharmacology and Early Development having completed clinical training in both General Internal Medicine and Clinical Pharmacology & Therapeutics. Christopher has worked in drug development for over a decade, initially as a clinical academic at King’s College London, before working in industry for the past four years. Prior to joining tranScrip he was a Senior Director at GSK within the Respiratory and Immunology Research Unit, with responsibilities spanning from target identification strategies to the submission of marketing authorisation applications.

Christopher has extensive experience of working with biopharmaceuticals and small molecules targeting both immunological and non-immunological mechanisms. He has worked across many therapeutic areas and has a particular interest in cardiovascular, nephrology, respiratory and rare diseases. During his clinical training he delivered cardiovascular clinics with a focus on lipids and hypertension.

Christopher has been responsible for the design and medical oversight of multiple early-phase studies, providing clinical leadership on the integration of translational science with a tractable clinical development plan. He has expertise in indication evaluation, biomarker strategy and developing early product profiles. As a matrix team leader, he was worked extensively with colleagues in commercial, regulatory and safety, and has a comprehensive understanding of the requirements to develop a molecule into a medicine.

Christopher completed his medical degree at the University of Cambridge and University College London, before reading for his PhD at King’s College London. Prior to joining industry, he was awarded a NIHR Clinical Lectureship, and worked with NICE during this time. At GSK he chaired both the Clinical Radiation Advisory Group, and the Clinical Insight Seminars.

Christopher is a member of the Royal College of Physicians and a fellow of the Higher Education Authority, the British Pharmacological Society and the Faculty of Pharmaceutical Medicine. He sits on a number of committees at the British Pharmacological Society.